wedzwefrststvwvz
  • Agenda
    • Programs
    • Symposia
    • Breakout Discussions
    • Short Courses
    • Plenary Keynotes
    • Speaker Biographies
    • Training Seminars
    • Attendees
    • About
    • Archives
  • Sponsor/Exhibitor
    • Attendee Demographics + Event Features
    • Sponsorship Opportunities
    • Current Sponsors
    • Current Exhibitors/Floorplan
    • Exhibit Contract
    • Exhibit Services Schedule
    • Exhibitor Prospectus
    • Lead Generation Opportunities
    • FAQs
  • Downloads
    • Downloads
    • Interviews
    • Podcasts
  • Travel
  • Posters
  • Press
  • Register
    • Commercial Registration
    • Academic Registration
    • Student Fellowship
    • Registration Offerings

Downloads

Discovery on Target
2018 Final Brochure

Discovery on Target
2018 Antibodies Brochure

Discovery on Target
2017 Final Brochure

Discovery on Target
2016 Final Brochure

Outlook YouTube Facebook LinkedIn Twitter
#BostonDOT18

cta-prelim-agenda
View All Sponsors
View Media Partners
DOT Target Stats

September 26-27

  • Small Molecules for Cancer Immunotherapy
  • NK Cell-Based Cancer Immunotherapy

September 27-28

  • Autoimmune and Inflammation Drug Targets
  • Targeting Tumor Myeloid Cells

September 26-27

  • Targeting the Ubiquitin-Proteasome System
  • CNS and Neurodegenerative Targets
  • Constrained Peptides and Macrocyclics
  • Target Identification & Validation – Part 1

September 27-28

  • Kinase Inhibitor Discovery
  • GPCR-Based Drug Discovery
  • Lead Generation Strategies
  • Target Identification & Validation – Part 2

September 26-27

  • Antibacterial Discovery and Development
  • NASH and Fibrosis

September 27-28

  • Targeting Gram-Negative Pathogens
  • Targeting the Microbiome

September 26-27

  • Antibody Discovery Forum – Part 1
  • Antibodies Against Membrane Protein Targets – Part 1

September 27-28

  • Antibody Discovery Forum – Part 2
  • Antibodies Against Membrane Protein Targets – Part 2
  • Antivirals: Targeting HBV and Beyond
  • Targeting Autophagy
  • Regenerative Medicine

September 26-27

  • Machine Learning for Effective Drug Discovery Decisions

September 27-28

  • Introduction to Small Molecule Drug Discovery and Development

CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Genomics

Healthcare

IT & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers

Request Information

Privacy Policy